
UC student’s co-op leads to full-time job with sweat sensor startup
UC biomedical engineering alumna Hannah Tilley. Photo/Provided
When it comes to monitoring health, sweat may be the next big thing. A Cincinnati-based startup company, Eccrine Systems, Inc., develops advanced wearable devices that capture and sense biomarkers from sweat. Medical professionals can apply these sweat-sensing devices to fields ranging from athletics to pediatrics to pharmaceutical monitoring.
Eccrine’s innovative research is what initially drew University of Cincinnati student Hannah Tilley to the company. Tilley, a 2018 graduate of UC’s biomedical engineering program, spent her final two cooperative education (co-op) rotations with Eccrine. She now works there full time as a research engineer.
“I have always loved helping others, and I wanted that to be a priority in my life” Tilley said. “I also enjoy tinkering with and building things. I landed on biomedical engineering because it was a good combination of both [these interests].”
Tilley got a taste of the medical industry with Assurex Health on her first co-op rotation. For the next two rotations, she worked at the molecular genetics lab at Cincinnati Children’s Hospital Medical Center.
“That co-op [with Cincinnati Children’s] showed me that I like the research aspect of the field, in that I like making new discoveries,” Tilley said.
But something was still missing. Though she found her passion for research in the lab, Tilley missed the hands-on aspect of building things. She found the perfect combination of research and development at Eccrine.
“When I was looking for my last coop rotation, I saw Eccrine,” Tilley said. “Knowing that they’re on the cutting edge of science is what really drew me in.”
On co-op at Eccrine, Tilley led the testing of an integrated flow sensor. As sweat is released from the sweat glands in your skin, a collector on the skin gathers sweat that flows into a channel. Tilley analyzed this flow rate to evaluate the efficiency of the flow from skin to the sensors.
Tilley enjoyed the responsibilities that Eccrine gave her, as well as the combination of hands-on work and research. When Eccrine asked her to stay on full time, it was an easy decision.
“I love it here,” Tilley said. “I love the people, the work, the company and what it stands for.”
Eccrine is only one of two companies in the world performing this kind of sweat-sensing research. As the innovative startup continues developing this technology, the potential applications – from military and industry to sports and medicine – seem endless.
For Tilley, that means a lot more opportunity to build on her passion for discovery, a passion she fully developed through her time at UC.
Featured image at top: UC biomedical engineering alumna Hannah Tilley works on a sweat sensor project. Photo/Provided
Related Stories
UC College of Medicine students honored as Physicians of Tomorrow
June 6, 2025
Two UC College of Medicine students, Delia Sosa and Lauren Schaffer, have been awarded the prestigious AMA Foundation Physicians of Tomorrow scholarship, recognizing their leadership, advocacy and vision for the future of health care.
Ohio medical regulators raise concerns over retail IV therapy...
June 6, 2025
On May 15, the State Medical Board of Ohio, Ohio Board of Pharmacy and Ohio Board of Nursing issued a joint regulatory statement addressing patient safety concerns when it comes to retail IV therapy clinics. The clinics administer a combination of saline, vitamins, electrolytes and amino acids, as well as headache relief and anti-nausea medications through an intravenous drip. Clinics in the Cincinnati area have made claims that their treatments can treat dehydration better than water alone, while also boosting immunity, improving gut health and maintaining healthy joints. On Cincinnati Edition recently, experts talked about the risks associated with retail IV hydration and if these services offer effective solutions to the health concerns they target.
UC biologists target lifecycle of deadly parasite
June 6, 2025
Researchers at the University of Cincinnati are exploring ways to interrupt the lifecycle of a parasite behind Chagas disease, offering hope of developing a cure.